Literature DB >> 15556804

Surgical treatment for Parkinson's disease.

Benjamin L Walter1, Jerrold L Vitek.   

Abstract

Since the early 1930s, physicians have developed and refined various surgical therapies for the treatment of Parkinson's disease. In this review we examine some of the problems associated with early surgical therapies, the development of new techniques and targets, and the results of clinical trials examining the safety and efficacy of these techniques. Ablative techniques include pallidotomy, thalamotomy, and, more recently, subthalamotomy. Because of concern over the high incidence of side-effects associated with bilateral ablative procedures, alternative approaches were explored. Deep brain stimulation (DBS) was subsequently developed and successfully applied in the internal globus pallidus, subthalamic nucleus, and thalamus for the treatment of Parkinson's disease. Recent approaches include biological neurorestorative techniques--surgical therapies with transplantation, gene therapy, and growth factors are all being studied. Although a great deal of work remains to be done, advances in surgical therapies for the treatment of Parkinson's disease are moving forward at an unprecedented pace.

Entities:  

Mesh:

Year:  2004        PMID: 15556804     DOI: 10.1016/S1474-4422(04)00934-2

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  34 in total

1.  Site of deep brain stimulation and jaw velocity in Parkinson disease.

Authors:  Lee T Robertson; Rebecca J St George; Patricia Carlson-Kuhta; Penelope Hogarth; Kim J Burchiel; Fay B Horak
Journal:  J Neurosurg       Date:  2011-08-12       Impact factor: 5.115

2.  Effects of depression and social support on comprehension and recall of informed consent information among Parkinson disease patients and their caregivers.

Authors:  Ellen J Teng; Nancy J Petersen; Christine Hartman; Ellen Matthiesen; Michael Kallen; Karon F Cook; Marvella E Ford
Journal:  Int J Psychiatry Med       Date:  2012       Impact factor: 1.210

3.  Tissue and electrode capacitance reduce neural activation volumes during deep brain stimulation.

Authors:  Christopher R Butson; Cameron C McIntyre
Journal:  Clin Neurophysiol       Date:  2005-10       Impact factor: 3.708

Review 4.  Parkinson's disease and primate research: past, present, and future.

Authors:  E A C Pereira; T Z Aziz
Journal:  Postgrad Med J       Date:  2006-05       Impact factor: 2.401

5.  Effects of Sertoli cell-conditioned medium on ventral midbrain neural stem cells: a preliminary report.

Authors:  Rania Shamekh; Samuel Saporta; Don F Cameron; Alison E Willing; Cindy D Sanberg; Karl Johe; P R Sanberg
Journal:  Neurotox Res       Date:  2008 May-Jun       Impact factor: 3.911

6.  Current steering to control the volume of tissue activated during deep brain stimulation.

Authors:  Christopher R Butson; Cameron C McIntyre
Journal:  Brain Stimul       Date:  2008-01       Impact factor: 8.955

7.  Deep brain stimulation activation volumes and their association with neurophysiological mapping and therapeutic outcomes.

Authors:  C B Maks; C R Butson; B L Walter; J L Vitek; C C McIntyre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-04-10       Impact factor: 10.154

Review 8.  Unusual complications of deep brain stimulation.

Authors:  Fumin Tong; Adolfo Ramirez-Zamora; Lucy Gee; Julie Pilitsis
Journal:  Neurosurg Rev       Date:  2014-10-25       Impact factor: 3.042

9.  Deep brain stimulation does not silence neurons in subthalamic nucleus in Parkinson's patients.

Authors:  Jonathan D Carlson; Daniel R Cleary; Justin S Cetas; Mary M Heinricher; Kim J Burchiel
Journal:  J Neurophysiol       Date:  2009-12-02       Impact factor: 2.714

Review 10.  Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases.

Authors:  Robert D Wyse; Gary L Dunbar; Julien Rossignol
Journal:  Int J Mol Sci       Date:  2014-01-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.